Cargando…

Cycloastragenol: An exciting novel candidate for age-associated diseases

Cycloastragenol (CAG) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus (Fisch.) Bunge. An increasing body of evidence has indicated that CAG has a wide spectrum of pharmacological functions, which are attracting attention in the res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yongjie, Zhou, Limin, Yang, Yajun, Liu, Yuyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122403/ https://www.ncbi.nlm.nih.gov/pubmed/30186456 http://dx.doi.org/10.3892/etm.2018.6501

Ejemplares similares

The construction of oligonucleotide-cycloastragenol and the renoprotective effect study
por: Tang, Lumin, et al.
Publicado: (2022)

Transcriptomic analysis reveals responses to Cycloastragenol in Arabidopsis thaliana
por: Mhiri, Wissem, et al.
Publicado: (2020)

Cycloastragenol Inhibits Experimental Abdominal Aortic Aneurysm Progression
por: Melin, Leander Gaarde, et al.
Publicado: (2022)

Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice
por: Zhang, Yanghuan, et al.
Publicado: (2023)

The Potential Role of Cycloastragenol in Promoting Diabetic Wound Repair In Vitro
por: Cao, Yi, et al.
Publicado: (2019)

Cycloastragenol alleviates airway inflammation in asthmatic mice by inhibiting autophagy
por: Zhu, Xueyi, et al.
Publicado: (2021)

Using UPLC-LTQ-Orbitrap-MS and HPLC-CAD to Identify Impurities in Cycloastragenol, Which Is a Pre-Clinical Candidate for COPD
por: Zhu, Feng, et al.
Publicado: (2023)

PLC1 mediated Cycloastragenol-induced stomatal movement by regulating the production of NO in Arabidopsis thaliana
por: Kong, Juantao, et al.
Publicado: (2023)

Antitumor Effect of Cycloastragenol in Colon Cancer Cells via p53 Activation
por: Park, Doil, et al.
Publicado: (2022)

Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice
por: Luangmonkong, Theerut, et al.
Publicado: (2023)

Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia
por: Li, Man, et al.
Publicado: (2020)

Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms
por: Ran, Ruixue, et al.
Publicado: (2016)

TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice
por: Zhu, Xueyi, et al.
Publicado: (2022)

Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation
por: Deng, Guoliang, et al.
Publicado: (2022)

Functional characterization of a cycloartenol synthase and four glycosyltransferases in the biosynthesis of cycloastragenol-type astragalosides from Astragalus membranaceus
por: Duan, Yangyang, et al.
Publicado: (2023)

Cycloastragenol as an Exogenous Enhancer of Chondrogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. A Morphological Study
por: Szychlinska, Marta Anna, et al.
Publicado: (2020)

Cycloastragenol, a Triterpenoid Saponin, Regulates Oxidative Stress, Neurotrophic Dysfunctions, Neuroinflammation and Apoptotic Cell Death in Neurodegenerative Conditions
por: Ikram, Muhammad, et al.
Publicado: (2021)

Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose-induced senescence and apoptosis
por: Hong, Haofeng, et al.
Publicado: (2021)

Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway
por: Lin, Weibin, et al.
Publicado: (2022)

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
por: Wang, Gang, et al.
Publicado: (2022)

Polygonum multiflorm alleviates glucocorticoid-induced osteoporosis and Wnt signaling pathway
por: Zhou, Manru, et al.
Publicado: (2018)

Methionine restriction - Association with redox homeostasis and implications on aging and diseases
por: Jelleschitz, Julia, et al.
Publicado: (2022)

Theoretical investigation of the effects of various substituents on the large energy gap between triplet excited-states of anthracene
por: Dawei, Yu, et al.
Publicado: (2018)

Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
por: Wu, Wen-Yu, et al.
Publicado: (2017)

Metformin: A Potential Candidate for Targeting Aging Mechanisms
por: Hu, Die, et al.
Publicado: (2021)

Exciting excitable brains: an update on migraine pathophysiology
por: Aurora, Sheena K.
Publicado: (2003)

Sirtuins and their Biological Relevance in Aging and Age-Related Diseases
por: Zhao, Lijun, et al.
Publicado: (2020)

Novel insights into ferroptosis: Implications for age-related diseases
por: Zhou, Ren-Peng, et al.
Publicado: (2020)

Potential Active Marine Peptides as Anti-Aging Drugs or Drug Candidates
por: Yang, Hui, et al.
Publicado: (2023)

Thymoquinone, as a Novel Therapeutic Candidate of Cancers
por: Almajali, Belal, et al.
Publicado: (2021)

Essential Oils as Novel Anthelmintic Drug Candidates
por: Panda, Sujogya Kumar, et al.
Publicado: (2022)

Comprehensive insight into endothelial progenitor cell-derived extracellular vesicles as a promising candidate for disease treatment
por: Chen, Ke, et al.
Publicado: (2022)

Therapeutic Candidates for Alzheimer’s Disease: Saponins
por: Zhang, Ruifeng, et al.
Publicado: (2023)

Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma
por: Lu, Louise J., et al.
Publicado: (2017)

Hypothalamic Kisspeptin Expression in Hyperandrogenic Female Rats and Aging Rats
por: Iwata, Kinuyo, et al.
Publicado: (2019)

Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases
por: Liuzzi, Grazia Maria, et al.
Publicado: (2023)

Drug Candidates for Autoimmune Diseases
por: Saurin, Sabrina, et al.
Publicado: (2022)

Radial excitations of $\overline{q}q$ mesons and non-$\overline{q}q$ candidates
por: Montanet, Lucien
Publicado: (1999)

Autophagy in ageing and ageing-associated diseases
por: He, Li-qiang, et al.
Publicado: (2013)

Novel HCN1 Mutations Associated With Epilepsy and Impacts on Neuronal Excitability
por: Xie, Changning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_21uostth4lbh4nd91pjl32c5sm